Related Experiment Video
Updated: Jul 19, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Resting state oscillatory brain dynamics in Parkinson's disease: an MEG study
J L W Bosboom1, D Stoffers, C J Stam
1Department of Neurology, Institute for Clinical and Experimental Neurosciences, VU University Medical Center, Amsterdam, The Netherlands. bosboom@vumc.nl
Summary
Parkinson's disease (PD) alters brain activity, with dementia patients showing further slowing across more frequency bands. This suggests additional mechanisms contribute to cognitive decline in PD beyond initial neuropathology.
Area of Science:
- Neuroscience
- Neurology
- Biophysics
Background:
- Cognitive dysfunction and dementia in Parkinson's disease (PD) pathogenesis remains incompletely understood.
- Altered resting-state brain activity patterns may indicate underlying neuropathological changes.
- Magnetoencephalography (MEG) offers a non-invasive method to investigate brain activity.
Purpose of the Study:
- To investigate differences in resting-state oscillatory brain activity patterns.
- To compare demented PD patients, non-demented PD patients, and healthy controls.
- To elucidate the electrophysiological underpinnings of cognitive decline in PD.
Main Methods:
- Magnetoencephalography (MEG) recordings were obtained from 13 demented PD patients, 13 non-demented PD patients, and 13 healthy controls.
- Resting-state conditions (eyes closed and eyes open) were assessed.
- Relative spectral power was calculated in delta, theta, alpha, beta, and gamma frequency bands using Fast Fourier Transformation.
Main Results:
- Non-demented PD patients exhibited increased theta and decreased beta power compared to controls.
- Demented PD patients showed further slowing, with increased delta/theta and decreased alpha/beta/gamma power relative to non-demented PD patients.
- Demented PD patients displayed significantly reduced reactivity to eye-opening.
Conclusions:
- Parkinson's disease is characterized by a general slowing of resting-state brain activity.
- Dementia in PD is associated with an additional, more widespread slowing of brain activity and reduced sensory reactivity.
- These distinct patterns suggest progressive neuropathology and additional mechanisms in PD dementia development.
More Related Videos
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...